At the 61st ASH Annual Meeting & Exposition, Raajit Rampal, Memorial Sloan Kettering Cancer Center, discusses his presentation: Approaches to the Individualized Management of MPNs: Best Practices and Guidance to Optimize Care.
Questions
1. Given the variable nature of myeloproliferative neoplasms (MPNs), what is the best way of assessing symptom burden? (0:05)
2. How has increased knowledge of the molecular biology of MPNs affected patient management? (0:42)
3. With an increasingly complex treatment regimen, what factors should be considered when selecting and sequencing therapies? (1:55)
4. What novel therapeutic targets are being investigated for MPNs? (3:19)
5. When and how should response assessment be performed? (4:39)
Raajit Rampal has received consultancy fees from Incyte Constellation, Celgene, Blueprint, Stemline, Promedior, Kartos.
Filmed at the 61st ASH Annual Meeting & Exposition 2019, Orlando, FL, USA.
